BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 20624444)

  • 1. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
    Bossong MG; Niesink RJ
    Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
    Cohen M; Solowij N; Carr V
    Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
    Schneider M
    Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and the developing brain: insights from behavior.
    Trezza V; Cuomo V; Vanderschuren LJ
    Eur J Pharmacol; 2008 May; 585(2-3):441-52. PubMed ID: 18413273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurophysiology of cannabis].
    Spadone C
    Encephale; 1991; 17(1):17-22. PubMed ID: 1688273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of cannabis.
    Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cannabis and Schizophrenia: new findings in an old debate].
    Kawohl W; Rössler W
    Neuropsychiatr; 2008; 22(4):223-9. PubMed ID: 19080993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long lasting consequences of cannabis exposure in adolescence.
    Rubino T; Parolaro D
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S108-13. PubMed ID: 18358595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use and the risk of later schizophrenia: a review.
    Smit F; Bolier L; Cuijpers P
    Addiction; 2004 Apr; 99(4):425-30. PubMed ID: 15049742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and psychosis: an update on course and biological plausible mechanisms.
    Linszen D; van Amelsvoort T
    Curr Opin Psychiatry; 2007 Mar; 20(2):116-20. PubMed ID: 17278907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
    López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
    Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Can Rats Tell Us about Adolescent Cannabis Exposure? Insights from Preclinical Research.
    Renard J; Rushlow WJ; Laviolette SR
    Can J Psychiatry; 2016 Jun; 61(6):328-34. PubMed ID: 27254841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
    Rubino T; Zamberletti E; Parolaro D
    J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain.
    Gómez M; Hernández M; Fernández-Ruiz J
    Brain Res; 2007 May; 1145():48-55. PubMed ID: 17320842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.